Disease Eradication: What Does It Take to Wipe out a Disease?
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case- control study and a mechanistic study of post-vaccination immune responses - The Lancet Infectious
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
Enhancing genetic disease control by selecting for lower host infectivity and susceptibility | Heredity
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Eliminated vs. Eradicated: Erasing disease from history — Atlantic Health Partners
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection - ScienceDirect
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
Vaccines have helped eradicate major diseases in the US | World Economic Forum
Vaccine and vaccination as a part of human life: In view of COVID‐19 - K.B. - 2022 - Biotechnology Journal - Wiley Online Library
Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Designing spatial and temporal control of vaccine responses | Nature Reviews Materials
The role of vaccines in combatting antimicrobial resistance | Nature Reviews Microbiology
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
Measles - The Lancet
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances
MMWR COVID-19 Reports | MMWR
Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Peptides for Vaccine Development | ACS Applied Bio Materials
